Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 admin Website Related Posts Trump’s Fed Feud: Fears Over Fed Independence Benefit Gold November 12, 2025 China Grants Conditional Approval to Codelco-SQM Lithium Joint Venture November 12, 2025 Mine life extensions indicated with Laverton drilling November 12, 2025